Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05811780

The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry

A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Treatment with any kind of extracorporeal organ support

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. Hospital survival

    Time frame: 30 days

    Survival of index hospitalization (yes/no)

Other outcomes

  1. Mesenteric ischemia

    Time frame: 30 days

    Occurrence of mesenteric ischemia

  2. Fluid balance

    Time frame: 7 days

    Patient fluid balance (difference between fluid input and output)

  3. ECMO run-time

    Time frame: 60 days

    Duration of ECMO support

Study contacts

Contact information is provided by the study sponsor or research team.

Alexander Supady, PD Dr.

CONTACT

[email protected]

+49761270 ext. 73790

Tobias Wengenmayer, Prof. Dr.

CONTACT

[email protected]

+49761270 ext. 35910

Sponsors and collaborators

Lead sponsor

University Hospital Freiburg

Other

Registry information

Important dates

Study start
2014
Primary completion
2030
Study completion
2035
First posted
Apr 13, 2023
Registry last updated
Apr 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.